Log in

Inuvo Stock Forecast, Price & News

+0.01 (+2.58 %)
(As of 09/21/2020 12:00 AM ET)
Today's Range
Now: $0.40
50-Day Range N/A
52-Week Range
Now: $0.40
Volume1.47 million shs
Average Volume3.95 million shs
Market Capitalization$38.76 million
P/E RatioN/A
Dividend YieldN/A
Inuvo, Inc., together with its subsidiaries, a technology company, provides data-driven platforms that automatically identify and message online audiences across video, mobile, connected TV, display, and social and native devices, channels, and formats in the United States. The company's digital marketplace allows advertisers and publishers the opportunity to buy and sell advertising space in real time. Its products and services include ValidClick, a software as a service and delivery platform for publishers that offers a pay-per-click solution where advertisements are targeted to consumers based on content and behaviors; IntentKey, a consumer intent recognition system designed to reach targeted mobile and desktop in-market audiences; and Digital Publishing in branded Web properties in categories of health, finance, travel, entertainment, careers, education, lifestyle, and automotive. The company's marketing channels consist of Websites, social media, blogs, public relations, trade shows, and conferences. Inuvo, Inc. was incorporated in 1987 and is headquartered in Little Rock, Arkansas.
Read More
Inuvo logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.22 out of 5 stars

Industry, Sector and Symbol

Industry Marketing Services



Sales & Book Value

Annual SalesN/A



Market Cap$38.76 million
Next Earnings Date11/12/2020 (Estimated)
OptionableNot Optionable
+0.01 (+2.58 %)
(As of 09/21/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive INUV News and Ratings via Email

Sign-up to receive the latest news and ratings for INUV and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Inuvo (NYSEAMERICAN:INUV) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Inuvo?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Inuvo in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Inuvo

When is Inuvo's next earnings date?

Inuvo is scheduled to release its next quarterly earnings announcement on Thursday, November 12th 2020.
View our earnings forecast for Inuvo

How were Inuvo's earnings last quarter?

Inuvo Inc (NYSEAMERICAN:INUV) released its quarterly earnings data on Thursday, August, 13th. The technology company reported ($0.02) earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.02. The technology company had revenue of $7.59 million for the quarter, compared to the consensus estimate of $9.47 million.
View Inuvo's earnings history

What price target have analysts set for INUV?

2 brokerages have issued 1-year price objectives for Inuvo's shares. Their forecasts range from $0.60 to $0.60. On average, they anticipate Inuvo's share price to reach $0.60 in the next twelve months. This suggests a possible upside of 51.0% from the stock's current price.
View analysts' price targets for Inuvo

Are investors shorting Inuvo?

Inuvo saw a decrease in short interest in August. As of August 31st, there was short interest totaling 1,180,000 shares, a decrease of 29.3% from the August 15th total of 1,670,000 shares. Based on an average trading volume of 6,770,000 shares, the short-interest ratio is presently 0.2 days.
View Inuvo's Short Interest

Who are some of Inuvo's key competitors?

What other stocks do shareholders of Inuvo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Inuvo investors own include Nokia Oyj (NOK), Biocept (BIOC), Ibio (IBIO), Ceragon Networks (CRNT), Inovio Pharmaceuticals (INO), Inpixon (INPX), Plug Power (PLUG), Actinium Pharmaceuticals (ATNM), Opko Health (OPK) and BIOLASE (BIOL).

Who are Inuvo's key executives?

Inuvo's management team includes the following people:
  • Mr. Richard K. Howe, Exec. Chairman & CEO (Age 56)
  • Mr. Wallace D. Ruiz Sr., CFO & Sec. (Age 68)
  • Mr. Don Walker Barrett III, Chief Operating Officer (Age 54)
  • Mr. Rick Anderson, Chief Information Officer
  • Mr. John B. Pisaris J.D., Esq., Gen. Counsel (Age 53)

What is Inuvo's stock symbol?

Inuvo trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "INUV."

Who are Inuvo's major shareholders?

Inuvo's stock is owned by many different institutional and retail investors. Top institutional investors include Bridgeway Capital Management Inc. (0.42%). Company insiders that own Inuvo stock include Charles D Morgan, Patrick Terrell and Richard K Howe.
View institutional ownership trends for Inuvo

Which institutional investors are buying Inuvo stock?

INUV stock was bought by a variety of institutional investors in the last quarter, including Bridgeway Capital Management Inc.. Company insiders that have bought Inuvo stock in the last two years include Charles D Morgan, Patrick Terrell, and Richard K Howe.
View insider buying and selling activity for Inuvo

How do I buy shares of Inuvo?

Shares of INUV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Inuvo's stock price today?

One share of INUV stock can currently be purchased for approximately $0.40.

How big of a company is Inuvo?

Inuvo has a market capitalization of $38.76 million. Inuvo employs 60 workers across the globe.

What is Inuvo's official website?

The official website for Inuvo is inuvo.com.

How can I contact Inuvo?

Inuvo's mailing address is 500 President Clinton Ave Ste 300, LITTLE ROCK, AR 72201-1760, United States. The technology company can be reached via phone at +1-501-2058508.

This page was last updated on 9/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.